Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression Post author: Post published:October 4, 2023 Post category:uncategorized Researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2). You Might Also Like The equity imperative: A roundtable on transforming healthcare January 9, 2024 New fiber probe enables real-time monitoring of key biomarkers April 22, 2026 Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics October 25, 2023
Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics October 25, 2023